Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had a liver biopsy confirming chronic hepatitis B (CHB) and/or non-alcoholic fatty liver disease (NAFLD) at the start of the study
- People of Chinese ethnicity
- People who have been followed up or monitored for more than 12 months
Who may not be able to join:
- People who have other types of liver disease
- People whose fatty liver is caused by something other than lifestyle or metabolic factors (confirm with trial site)
- People who drink alcohol heavily or have a history of alcohol misuse
- People who already had liver cirrhosis, complications related to cirrhosis, or liver cancer at the start of the study
- People who have or have had any form of cancer
- People who have previously had a liver transplant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +852 2861 3777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of patients with liver cirrhosis, hepatic encephalopathy, esophageal varices, ascites and hepatocellular carcinoma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.